Navigation Links
Danaher to Acquire Beckman Coulter, Inc.
Date:2/7/2011

ffer or the subsequent merger may not be satisfied or waived, including that a governmental entity may prohibit, delay or refuse to grant approval for the consummation of the acquisition; other uncertainties pertaining to the business of the Company or Danaher; product safety; legislative and regulatory activity and oversight; the continuing global economic uncertainty and other risks detailed in (i) the Company's public filings with the SEC from time to time, including the Company's most recent Annual Report on Form 10-K for the year ended December 31, 2009, Quarterly Reports on Form 10-Q and its subsequently filed SEC reports, each as filed with the SEC, and (ii) Danaher's public filings with the SEC from time to time, including Danaher's most recent Annual Report on Form 10-K for the year ended December 31, 2009, Quarterly Reports on Form 10-Q and its subsequently filed SEC reports, each as filed with the SEC, in each case, which contains and identifies important factors that could cause actual results to differ materially from those contained in the forward-looking statements. The reader is cautioned not to unduly rely on these forward-looking statements. Each of the Company and Danaher expressly disclaims any intent or obligation to update or revise publicly these forward-looking statements except as required by law.Contacts:

Beckman CoulterCynthia SkoglundInvestor Relations(714) 961-6320DanaherMatt McGrewInvestor Relations(202) 828-0860
'/>"/>

SOURCE Beckman Coulter, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Thoratec Announces Early Termination of HSR Waiting Period for the Sale of ITC to Danaher Corporation
2. Danaher Reports Record Third Quarter 2010 Results
3. Danaher to Present at Upcoming Industry Conferences
4. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
5. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
6. Image Solutions, Inc. Acquires Zurich Biostatistics, Inc.
7. New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias
8. U.S. Preventive Medicine Acquires Specialty Disease Management
9. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
10. FDA Accepts Wyeths Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia
11. Nastech Reacquires Teriparatide (Parathyroid Hormone; PTH1-34) Nasal Spray from Procter & Gamble
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/5/2015)... UNION CITY, Calif. , Aug. 5, 2015 /PRNewswire/ ... company manufacturing point-of-care blood instrumentation and consumables to the ... Clint Severson , chairman and chief executive officer, will ... Growth Conference on Wednesday, August 12, 2015 at 1:00 ... InterContinental Hotel in Boston, MA. ...
(Date:8/5/2015)... -- Ardelyx, Inc. (NASDAQ: ARDX ), a clinical-stage biopharmaceutical ... that Mike Raab , Chief Executive Officer, will ... PacGrow Healthcare Conference at 12:45 p.m. Eastern Time on ... New York City . The ... accessible through a link in the Investor Relations section ...
(Date:8/5/2015)... VIEJO, Calif. , Aug. 5, 2015 /PRNewswire/ ... provider of semiconductor solutions differentiated by power, security, ... the smallest radio module it has ever produced. ... medical devices such as pacemakers, cardiac defibrillators and ... new radio module supersedes the company,s ZL70321 and ...
Breaking Medicine Technology:Ardelyx to Present at the 2015 Wedbush PacGrow Healthcare Conference 2Microsemi's New RF Module Speeds Time-to-Market for Implantable Medical Device Designers 2Microsemi's New RF Module Speeds Time-to-Market for Implantable Medical Device Designers 3Microsemi's New RF Module Speeds Time-to-Market for Implantable Medical Device Designers 4Microsemi's New RF Module Speeds Time-to-Market for Implantable Medical Device Designers 5
... May 21, 2007/PRNewswire-FirstCall/ -- Bristol-Myers,Squibb Company (NYSE: ... which showed that treatment with Baraclude (entecavir),demonstrated ... 48 weeks,-- a result that was also ... These data from an open-label, randomized viral ...
... -- Data presented,today at a major medical meeting ... for five days is as,effective as standard therapy ... treatment of complicated urinary tract infections,(cUTI) and acute ... markets LEVAQUIN in the,U.S., presented the data during ...
Cached Medicine Technology:Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 2Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 3Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 4Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 5Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 6Five Days of LEVAQUIN(R) as Effective as 10 Days of Ciprofloxacin,in Complicated Urinary Tract Infections and Acute Pyelonephritis 2Five Days of LEVAQUIN(R) as Effective as 10 Days of Ciprofloxacin,in Complicated Urinary Tract Infections and Acute Pyelonephritis 3Five Days of LEVAQUIN(R) as Effective as 10 Days of Ciprofloxacin,in Complicated Urinary Tract Infections and Acute Pyelonephritis 4
(Date:8/5/2015)... ... ... of Chicago’s new elevated trail, the 606, has been getting a lot of press in ... Sedgebrook senior living community in Lincolnshire. Known as the Trailblazers, these robust hikers hit ... to more distant places. When they read about the 606 on Chicago’s Northwest Side, ...
(Date:8/5/2015)... ... August 05, 2015 , ... ... filed in the testosterone multidistrict litigation known as Testosterone Replacement Therapy Products Liability ... Northern District of Illinois. The Motion to Dismiss was filed by the defendants, ...
(Date:8/5/2015)... ... August 05, 2015 , ... Available in select spas and ... with a quartet of beauty-enhancing marine and plant oils. A perfect complement to Phytomer’s ... which stands out for its lovely scent and soothing properties. Formulated as a light ...
(Date:8/5/2015)... ... August 05, 2015 , ... It is exciting times ... global organisations such as PhUSE or CDISC are currently bringing in the harvest ... Japanese PMDA and the European EMA. A move towards global harmonisation of electronic ...
(Date:8/4/2015)... ... ... review site BestMillionaireDatingSites.com recently refreshed its list of the top dating platforms for wealthy ... service in the segment. , A representative from the site said, “You certainly cannot ... right dating platform so that they can make the most of it and find ...
Breaking Medicine News(10 mins):Health News:Sedgebrook Trailblazers Tread New Ground on Chicago’s New 606 Path 2Health News:Sedgebrook Trailblazers Tread New Ground on Chicago’s New 606 Path 3Health News:Testosterone Lawsuit News: Defendants Push Back Against RICO Claim 2Health News:Testosterone Lawsuit News: Defendants Push Back Against RICO Claim 3Health News:Testosterone Lawsuit News: Defendants Push Back Against RICO Claim 4Health News:Phytomer launches ROSÉE SOIN Radiance Replenishing Oil 2Health News:Phytomer launches ROSÉE SOIN Radiance Replenishing Oil 3Health News:Phytomer launches ROSÉE SOIN Radiance Replenishing Oil 4Health News:Japan PMDA Publishes English Versions of Electronic Data Submission & Technical Conformance Guidance 2Health News:Japan PMDA Publishes English Versions of Electronic Data Submission & Technical Conformance Guidance 3Health News:BestMillionaireDatingSites.com Publishes Reviews of the Best Dating Sites for Wealthy Singles 2
... from terminal cancer. The zoo officials are seeking to make ... as possible. // A large node or lymphoma has been ... developing rapidly. ,Even though surgeries have been ... to live for more than a few weeks as the ...
... more than 80 people in Asia and many countries fear that ... various researches are been done to develop a new dug to ... institute have found that Sambucol (an extract from elderberries) is very ... ,This is found to be 99% effective but they also ...
... samples and their personal information about their lifestyle, diet, ... two biggest medical research projects, the British Project called ... still in its infancy and the Biobank would be ... blood samples and your personal lifestyle information and they ...
... new study appearing in the January 18 issue of The ... triggered off when adult neurons try to undergo division. This ... behind the development of the disease. ,"If ... stop neurons from dying prematurely. This could be a fresh ...
... the Indian State of Bihar has been given the task ... Chief Minister is reported to have given him //the task ... ,Sources close to Nitish Kumar said his prime concern ... state, but eliminating mosquitoes was also a priority. The problem ...
... demand for medical staff, it has been proposed to ... role, currently played by nurses, podiatrist surgeons and other ... them into vacant postitions. // ,It has led ... The proposal would be taken up for consideration during ...
Cached Medicine News:Health News:Dividing Nerve Cells Could Trigger Alzheimer's Disease 2Health News:Additional Responsiblities To Be Taken Up By Allied Healthcare Professionals 2
The Quantum II Dual Wavelength Analyzer measures differential absorbances of liquid samples and converts those readings into analytical values....
... First Consolidated Workstation to Automate Deparaffinization, ... Staining,Now you can perform deparaffinization, pretreatment, ... routine slide washing with a single ... preprogrammed Vysis protocols for fluorescence in ...
... ABI Prism 7000 Sequence Detection System ... that detects and quantitates nulceic acid ... of accumulated PCR product is made ... detection, and application-specific software in a ...
... The CELL-DYN 1800 is the latest 3-part ... used since the founding of the CELL-DYN ... and data management capabilities, the CELL-DYN 1800 ... The CELL-DYN 1800 is smaller than its ...
Medicine Products: